Treatment Protocols

 

Assessment, Investigations and the Decision making process


Guidelines for Medical Decompressive Therapy


Intensity Modulated Radiotherapy (IMRT)


Stereotactic Irradiation (SRS and SRT)


Performance Scales

Follow-Up Policy

Primary Treatment Policies


Astrocytic Tumors (Gliomas)

Ependymomas

 

Tumors requiring Craniospinal Radiotherapy

 

>>Pituitary Tumors

>>Craniopharyngiomas

>>Meningiomas

>>Chordomas

Primary CNS Lymphomas

Spinal Tumors

 

Brain Metastasis


Pituitary Tumors

Craniopharyngiomas

Meningiomas

Chordomas

 

 

Pituitary Tumors

Management:

  • Completely excised non secretory adenoma: Surveillance

  • Incompletely excised non secretory adenoma, hormone secretory tumours (Acromegaly, Cushings, Prolactinoma, Nelsons syndrome) not controlled with surgery and /or medical therapy: 3D CRT/SCRT

Dose: 45Gy in 25# in 5 weeks (consider 4 field non coplanar MLC plan)

 

 

 

Craniopharyngiomas

Management:

  • Completely excised:  Surveillance

  • Incompletely excised /no surgery: RT/SCRT

Dose: 54Gy in 30# in 6 weeks

 

 

 

Meningiomas

Management of benign (low grade) lesions:

  • Completely excised: Surveillance

  • Incompletely excised /no surgery: local RT

Dose: 54Gyin 30# in 6 weeks


Anaplastic/Malignant meningioma- Localized RT.

Dose: 60Gy in 30# in 6 weeks

 

 

 

Chordomas 

Base of skull chordomas: 60-66 Gy, preferably with IMRT
Spinal chordomas: 50-54 Gy

 

 

Home

<Previous || Next>